Literature DB >> 26401087

Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C.

Keisuke Osakabe1, Naohiro Ichino1, Toru Nishikawa1, Hiroko Sugiyama1, Miho Kato1, Ai Shibata1, Wakana Asada1, Naoto Kawabe1, Senju Hashimoto1, Michihito Murao1, Takuji Nakano1, Hiroaki Shimazaki1, Toshiki Kan1, Kazunori Nakaoka1, Yuka Takagawa1, Masashi Ohki1, Takamitsu Kurashita1, Tomoki Takamura1, Kentaro Yoshioka1.   

Abstract

AIM: To evaluate the changes of shear-wave velocity (Vs) by acoustic radiation force impulse after treatment in chronic hepatitis C.
METHODS: Eighty-seven patients with chronic hepatitis C were consecutively treated with combinations of interferon (IFN) plus ribavirin (RBV). Vs value (m/s) was measured with acoustic radiation force impulse before treatment, at end of treatment (EOT), 1 year after EOT, and 2 years after EOT.
RESULTS: In patients with a sustained virological response (SVR) (n = 41), Vs significantly decreased at EOT [1.19 (1.07-1.37), P = 0.0004], 1 year after EOT [1.10 (1.00-1.22), P = 0.0001], and 2 years after EOT [1.05 (0.95-1.16), P < 0.0001] compared with baseline [1.27 (1.11-1.49)]. In patients with a relapse (n = 26), Vs did not significantly decrease at EOT [1.23 (1.12-1.55)], 1 year after EOT [1.20 (1.12-1.80)], and 2 years after EOT [1.41 (1.08-2.01)] compared with baseline [1.39 (1.15-1.57)]. In patients with a nonvirological response (n = 20), Vs did not significantly decrease at EOT [1.64 (1.43-2.06)], 1 year after EOT [1.66 (1.30-1.95)], and 2 years after EOT [1.61 (1.36-2.37)] compared with baseline [1.80 (1.54-2.01)]. Among genotype 1 patients, baseline Vs was significantly lower in SVR patients [1.28 (1.04-1.40)] than in non-SVR patients [1.56 (1.20-1.83)] (P = 0.0142).
CONCLUSION: Reduction of Vs values was shown in SVR patients after IFN-plus-RBV therapy by acoustic radiation force impulse.

Entities:  

Keywords:  Fibrosis; Hepatitis C virus; Interferon and ribavirin; Liver stiffness; Shear-wave velocity

Mesh:

Substances:

Year:  2015        PMID: 26401087      PMCID: PMC4572803          DOI: 10.3748/wjg.v21.i35.10215

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan.

Authors:  Jing-Houng Wang; Chi-Sin Changchien; Chao-Hung Hung; Wei-Chih Tung; Kwong-Ming Kee; Chien-Hung Chen; Tsung-Hui Hu; Chuan-Mo Lee; Sheng-Nan Lu
Journal:  J Gastroenterol Hepatol       Date:  2010-05       Impact factor: 4.029

3.  Reduction of liver stiffness by antiviral therapy in chronic hepatitis B.

Authors:  Keisuke Osakabe; Naohiro Ichino; Toru Nishikawa; Hiroko Sugiyama; Miho Kato; Shiho Kitahara; Senju Hashimoto; Naoto Kawabe; Masao Harata; Yoshifumi Nitta; Michihito Murao; Takuji Nakano; Hiroaki Shimazaki; Yuko Arima; Koji Suzuki; Kentaro Yoshioka
Journal:  J Gastroenterol       Date:  2011-08-06       Impact factor: 7.527

4.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

5.  Changes of non-invasive markers and FibroScan values during HCV treatment.

Authors:  J Vergniol; J Foucher; L Castéra; P-H Bernard; R Tournan; E Terrebonne; E Chanteloup; W Merrouche; P Couzigou; V de Lédinghen
Journal:  J Viral Hepat       Date:  2008-10-17       Impact factor: 3.728

6.  Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.

Authors:  Sarah L George; Bruce R Bacon; Elizabeth M Brunt; Kusal L Mihindukulasuriya; Joyce Hoffmann; Adrian M Di Bisceglie
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

7.  Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C.

Authors:  Toru Nishikawa; Senju Hashimoto; Naoto Kawabe; Masao Harata; Yoshifumi Nitta; Michihito Murao; Takuji Nakano; Yuko Mizuno; Hiroaki Shimazaki; Toshiki Kan; Kazunori Nakaoka; Yuka Takagawa; Masashi Ohki; Naohiro Ichino; Keisuke Osakabe; Kentaro Yoshioka
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

8.  Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

Authors:  Mireen Friedrich-Rust; Katrin Wunder; Susanne Kriener; Fariba Sotoudeh; Swantje Richter; Joerg Bojunga; Eva Herrmann; Thierry Poynard; Christoph F Dietrich; Johannes Vermehren; Stefan Zeuzem; Christoph Sarrazin
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.

Authors:  Eric Lawitz; Mark S Sulkowski; Reem Ghalib; Maribel Rodriguez-Torres; Zobair M Younossi; Ana Corregidor; Edwin DeJesus; Brian Pearlman; Mordechai Rabinovitz; Norman Gitlin; Joseph K Lim; Paul J Pockros; John D Scott; Bart Fevery; Tom Lambrecht; Sivi Ouwerkerk-Mahadevan; Katleen Callewaert; William T Symonds; Gaston Picchio; Karen L Lindsay; Maria Beumont; Ira M Jacobson
Journal:  Lancet       Date:  2014-07-28       Impact factor: 79.321

View more
  1 in total

1.  Shear wave elastography in hepatitis C patients before and after antiviral therapy.

Authors:  Toshikuni Suda; Osamu Okawa; Rion Masaoka; Yoshinori Gyotoku; Naohiko Tokutomi; Yasumi Katayama; Masaya Tamano
Journal:  World J Hepatol       Date:  2017-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.